Zhengye Biotechnology Holding Ltd. (ZYBT)
NASDAQ:ZYBT
Want to see ZYBT full AI Analyst Report?
Total Valuation
Zhengye Biotechnology Holding Ltd. has a market cap or net worth of $10.91M. The enterprise value is $24.75M.
Market Cap$10.91M
Enterprise Value$24.75M
Share Statistics
Zhengye Biotechnology Holding Ltd. has 10,965,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,965,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhengye Biotechnology Holding Ltd.’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -17.87%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-17.87%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee418.57K
Profits Per Employee-298.45K
Employee Count278
Asset Turnover0.27
Inventory Turnover2.36
Valuation Ratios
The current PE Ratio of Zhengye Biotechnology Holding Ltd. is ―. Zhengye Biotechnology Holding Ltd.’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Zhengye Biotechnology Holding Ltd. had revenue of 116.36M and earned -69.78M in profits. Earnings per share was 0.00.
Revenue116.36M
Gross Profit23.87M
Operating Income-68.25M
Pretax Income-71.87M
Net Income-69.78M
EBITDA-42.52M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Zhengye Biotechnology Holding Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.46
52-Week Price Change-91.36%
50-Day Moving Average6.15
200-Day Moving Average―
Relative Strength Index (RSI)35.40
Average Volume (3m)871.70K
Important Dates
Zhengye Biotechnology Holding Ltd. upcoming earnings date is Apr 28, 2026, Before Open (Confirmed).
Last Earnings DateJul 3, 2025
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Zhengye Biotechnology Holding Ltd. as a current ratio of 1.14, with Debt / Equity ratio of ―
Current Ratio1.14
Quick Ratio0.82
Debt to Market Cap0.00
Net Debt to EBITDA-0.58
Interest Coverage Ratio-20.07
Taxes
In the past 12 months, Zhengye Biotechnology Holding Ltd. has paid 11.10M in taxes.
Income Tax11.10M
Effective Tax Rate-0.15
Enterprise Valuation
Zhengye Biotechnology Holding Ltd. EV to EBITDA ratio is -0.58, with an EV/FCF ratio of 35.21.
EV to Sales0.21
EV to EBITDA-0.58
EV to Free Cash Flow35.21
EV to Operating Cash Flow1.86
Balance Sheet
Zhengye Biotechnology Holding Ltd. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of -58.66%, and net profit margin of -59.97%.
Gross Margin―
Operating Margin-58.66%
Pretax Margin-61.77%
Net Profit Margin-59.97%
EBITDA Margin-36.54%
EBIT Margin-58.84%
Analyst Forecast
The average price target for Zhengye Biotechnology Holding Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-37.53%
EPS Growth Forecast-717.42%